Literature DB >> 8187333

Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis.

B A Eberhard1, R M Laxer, U Andersson, E D Silverman.   

Abstract

The production of tumour necrosis factor-alpha (TNF-alpha), TNF-beta and IL-6 in synovial fluid was studied in 50 samples of synovial fluid from 44 children with juvenile rheumatoid arthritis (JRA) by identifying cytokine production at a single-cell level. Post Ficoll-separated synovial fluid mononuclear cells were permeabilized and then intracellular TNF-alpha, TNF-beta and IL-6 protein production was examined using indirect immunofluorescence and murine anti-cytokine MoAbs. All three cytokines were measured in 37 of the 50 samples. In 25 of the 37 samples there was complete concordance; all three cytokines were present in six and absent in 19 samples. At least one cytokine was present in 27/50 (54%) of synovial fluid samples. Overall, TNF-alpha was detected in 22/49 (45%) samples, TNF-beta in 15/41 (37%) and IL-6 in 16/45 (36%) samples. Five patients had serial arthrocentesis, and in these samples there were two patients who had initially positive cytokine production, which on subsequent measurement was negative; in the other three patients there was no change from the previous cytokine production. We provide evidence that synovial fluid mononuclear cells produce monocyte and T cell cytokines in JRA. These findings suggest a role for both T cell and macrophage products in the pathogenesis of JRA, and the potential for modulation of cytokine production as a target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187333      PMCID: PMC1534897          DOI: 10.1111/j.1365-2249.1994.tb06551.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Synovial fluid lymphocytes in different subtypes of juvenile rheumatoid arthritis.

Authors:  V Bergroth; Y T Konttinen; P Pelkonen; M Haapala; J Haapasaari; D Nordström; I Kunnamo; C Friman
Journal:  Arthritis Rheum       Date:  1988-06

2.  Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

Authors:  B Henderson; E R Pettipher
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation.

Authors:  E J Brewer; J Bass; J Baum; J T Cassidy; C Fink; J Jacobs; V Hanson; J E Levinson; J Schaller; J S Stillman
Journal:  Arthritis Rheum       Date:  1977-03

4.  Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis.

Authors:  F De Benedetti; P Robbioni; M Massa; S Viola; S Albani; A Martini
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

5.  Cytokine inter-relationships and their association with disease activity in arthritis.

Authors:  I Holt; R G Cooper; J Denton; A Meager; S J Hopkins
Journal:  Br J Rheumatol       Date:  1992-11

6.  Concomitant production of different lymphokines in activated T cells.

Authors:  U Andersson; B Sander; J Andersson; G Möller
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

7.  Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.

Authors:  S J Hopkins; A Meager
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction.

Authors:  O Førre; J H Dobloug; J B Natvig
Journal:  Scand J Immunol       Date:  1982-02       Impact factor: 3.487

9.  Detection of T-lymphocyte subpopulation in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies.

Authors:  O Førre; J Thoen; J H Dobloug; T Egeland; T K Kvien; O J Mellbye; J B Natvig
Journal:  Scand J Immunol       Date:  1982-02       Impact factor: 3.487

10.  Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.

Authors:  G S Firestein; W D Xu; K Townsend; D Broide; J Alvaro-Gracia; A Glasebrook; N J Zvaifler
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  Detection of TNF alpha and Fas ligand mRNA within synovial mononuclear cells by fluorescence in-cell labeling PCR (FICL-PCR).

Authors:  M Okubo; M P Brown; K Chiba; R Kasukawa; T Nishimaki
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

Review 3.  The development and assessment of biological treatments for children.

Authors:  Eve M D Smith; Helen E Foster; Michael W Beresford
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

4.  Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis.

Authors:  S Prahalad; J F Bohnsack; L B Jorde; A Whiting; B Clifford; D Dunn; R Weiss; M Moroldo; S D Thompson; D N Glass; M J Bamshad
Journal:  Genes Immun       Date:  2006-06-15       Impact factor: 2.676

5.  Intraarticular corticosteroids in refractory childhood Lyme arthritis.

Authors:  S Nimmrich; I Becker; G Horneff
Journal:  Rheumatol Int       Date:  2014-01-04       Impact factor: 2.631

Review 6.  Use of biologics in the treatment of childhood rheumatic diseases.

Authors:  T Arkachaisri; T J Lehman
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

7.  T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis.

Authors:  K Jiang; Y Chen; C-S Xu; J N Jarvis
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 8.  Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.

Authors:  Susan Shenoi; Carol A Wallace
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

9.  Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters.

Authors:  N Kutukculer; S Caglayan; F Aydogdu
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

10.  Prolonged synovitis in pediatric Lyme arthritis cannot be predicted by clinical or laboratory parameters.

Authors:  AnneMarie C Brescia; Carlos D Rose; Paul T Fawcett
Journal:  Clin Rheumatol       Date:  2009-02-05       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.